Latest

ketamine

Featured Genetics Neuroscience Open Neuroscience Articles

·March 11, 2020·2 min read

JNK protein triggers neurons to withdraw their synapses when stressed

Using optogenetics to inhibit the JNK protein prevented synapses from shrinking in response to stress.

Featured Neuroscience Open Neuroscience Articles

·November 26, 2019·5 min read

One shot of ketamine could reduce problem drinking

A single shot of ketamine administered to heavy drinkers following reactivation of their drinking memories led to a rapid decrease in the urge to drink. The effect lasted for over nine months.

Featured Neuroscience Neuroscience Videos Psychology

·November 18, 2019·4 min read

Side effects mild and brief with single antidepressant dose of intravenous ketamine

The side effects of administering ketamine to treat major depressive disorder are mild and persist for no longer than four hours, researchers report. Most of the side effects peaked within an hour of treatment, and many patients reported the effects as being significantly reduced two hours post ketamine administration.

Featured Neuroscience

·November 18, 2019·3 min read

Ketamine reduces drinking in male rats, but not females

Ketamine reduced alcohol intake in male rat models of alcohol use disorder but increased the desire for alcohol in low-consumption females.

Featured Neurology Neuroscience Pain

·October 21, 2019·2 min read

One in three pain patients suffer side effects after ketamine infusion therapy

35% of patients who used ketamine to manage pain reported significant side effects ranging from hallucination, out-of-body experiences, visual disturbances, and urinary dysfunction. 20% of the side effects were linked directly to ketamine, and 15% associated with ketamine in combination with other drugs.

Featured Neuroscience Psychology

·September 1, 2019·5 min read

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'.

Featured Neuroscience Psychology

·July 31, 2019·4 min read

Ketamine isn’t an opioid and treats depression in a unique way

A new study clarifies the mechanism behind how ketamine works as an antidepressant. Researchers say there is evidence to suggest ketamine binds to NMDA receptors, instead of opioid receptors. Reducing the belief that ketamine is an opioid may make patients with depression more open to using the treatment.

Featured Neuroscience Open Neuroscience Articles Psychology

·May 21, 2019·5 min read

Study supports effectiveness of new fast-acting antidepressant, esketamine nasal spray

Esketamine combined with antidepressants acts rapidly to help alleviate symptoms in those with treatment-resistant depression.

Featured Neuroscience Psychology

·May 16, 2019·5 min read

Ketamine: The illicit party psychedelic that promises to heal depression

Ketamine, an anesthetics which has been commonly used as an illicit party drug, is helping people overcome depression. The drug works rapidly and provides lasting relief from depressive symptoms for weeks after exposure. Researchers are examining how ketamine works in the brain to help positively influence behavior in those with mood disorders.

Featured Neuroscience Open Neuroscience Articles Psychology

·May 1, 2019·3 min read

Traces of Ketamine, Cocaine, Pharmaceuticals and Pesticides Found in Freshwater Shrimp

Researchers have found a diverse array of illicit drugs, including cocaine and ketamine, along with pesticides and pharmaceutical chemicals in British freshwater shrimp. While the concentrations of chemicals were considered low, researchers state there is a concern for the potential environmental risk this may pose to wildlife.

This shows how NV-5138 affects dendrites

Featured Neuroscience Open Neuroscience Articles Psychology

·April 17, 2019·3 min read

New drug mimics benefits of ketamine for depression

NV-5138, a small molecule drug that mimics the action of ketamine, provides fast-acting antidepressant responses in rodent models of depression. The drug is currently undergoing Phase 1 testing in humans.

Featured Neuroscience Open Neuroscience Articles Psychology

·April 11, 2019·3 min read

Ketamine reverses neural changes underlying depression-related behaviors: Mouse study

The formation of prefrontal cortex dendritic spine formation sustains the remission of depressive related symptoms and behaviors following ketamine treatment by restoring lost spines.

1 2 3 4 5 6 … 8

ketamine

JNK protein triggers neurons to withdraw their synapses when stressed

One shot of ketamine could reduce problem drinking

Side effects mild and brief with single antidepressant dose of intravenous ketamine

Ketamine reduces drinking in male rats, but not females

One in three pain patients suffer side effects after ketamine infusion therapy

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Ketamine isn’t an opioid and treats depression in a unique way

Study supports effectiveness of new fast-acting antidepressant, esketamine nasal spray

Ketamine: The illicit party psychedelic that promises to heal depression

Traces of Ketamine, Cocaine, Pharmaceuticals and Pesticides Found in Freshwater Shrimp

New drug mimics benefits of ketamine for depression

Ketamine reverses neural changes underlying depression-related behaviors: Mouse study

GPS of the Brain: Marmoset Gaze Reveals New Insights into Spatial Navigation

BigNeuron: Revolutionizing Neuron Reconstruction with AI

Vitamin D’s Crucial Role in Dopamine Function and Schizophrenia

Canine Brain Atlas Sheds Light on Evolution of Human Brain Function

Subscribe